Post-authorization safety study to assess the risk of diabetic ketoacidosis among type 2 diabetes mellitus patients treated with ertugliflozin compared to patients treated with other antihyperglycemic agents (MK-8835-062) First published 17/10/2019 Last updated 11/02/2025 EU PAS number:EUPAS31718 Study Finalised